Biotech

All Articles

Lilly- backed weight-loss biotech files IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted t...

Aelis' cannabis make use of drug flunks period 2b, driving Indivior to reconsider $100M alternative

.Aelis Farma's chances of protecting a simple, beneficial choice on a $100 million alternative payme...

ProKidney halts stage 3 test not needed for cell treatment authorization

.ProKidney has actually stopped one of a set of period 3 trials for its tissue treatment for renal c...

Vaxcyte climbs on 'magnificent' 31-valent PCV gain versus Pfizer

.Vaxcyte introduced what professionals called "remarkable" stage 1/2 records for its own 31-valent p...

Recursion's brain condition test shows insufficient proof of efficiency

.Recursion has discovered with an early exam of its own tech-enabled approach to medication discover...

Acepodia, Pfizer click on together for chemistry-based tissue therapy

.Phone it a case of great chemical make up: Acepodia, a biotech based upon Nobel Prize-winning scien...

Praxis epilepsy medicine decreases seizures in period 2 hearing

.Practice Preciseness Medicines has scored yet another midphase succeed in epilepsy this year, along...

Three directors surrender as Dyne articles combined data for DMD candidate

.After getting away from a medical hold numerous years back, Dyne Therapeutics has disclosed new sta...

Arrowhead fires off phase 3 records in uncommon metabolic health condition before market encounter Ionis

.Arrowhead Pharmaceuticals has revealed its own give in front of a potential showdown along with Ion...

Pfizer, Valneva show lyme disease try efficient for second enhancer

.Pfizer and also Valneva might have concerning 2 more years to hang around just before they help mak...